Answers are grounded in this paper and cite their sources.
This retrospective long-term observational study suggests that propranolol treatment may decrease HCC occurrence in patients with HCV cirrhosis. These findings need to be verified by prospective clinical trial.
No takes yet. Share an insight, caveat, or question.
Nkontchou et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: